D. Scott Coward - 21 Feb 2023 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
Director
Signature
/s/ D. Scott Coward by Mark R. Busch, attorney-in-fact
Issuer symbol
EXAS
Transactions as of
21 Feb 2023
Net transactions value
-$63,159
Form type
4
Filing time
23 Feb 2023, 15:22:34 UTC
Previous filing
16 Feb 2023
Next filing
01 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Options Exercise $0 +2,248 +8.5% $0.000000 28,741 21 Feb 2023 Direct F1
transaction EXAS Common Stock Sale $63,159 -1,007 -3.5% $62.72 27,734 22 Feb 2023 Direct F2
holding EXAS Common Stock 4,428 21 Feb 2023 Held in 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXAS Restricted Stock Units Options Exercise $0 -2,248 -33% $0.000000 4,495 21 Feb 2023 Common Stock 2,248 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock received upon vesting of a restricted stock unit award.
F2 Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on February 21, 2023.
F3 Each restricted stock unit represents a contingent right to receive one share of common stock.
F4 Represents a restricted stock unit award that partially vested on February 21, 2023. The restricted stock units vest in four equal annual installments beginning on February 19, 2022.